Alexandria Real Estate Equities (ARE) Stock
Real estate owner of life science campuses for biotech. Here's the price, business snapshot, and what's worth knowing about Alexandria Real Estate Equities in July 2026.
Alexandria Real Estate Equities, Inc. (ARE) is a specialised real‑estate investment trust (REIT) focused on owning, developing and operating life‑science and technology campuses, primarily in the United States. With a market capitalisation of about $13.28 billion, Alexandria leases lab and office space to biotech, pharmaceutical and research companies, often under long‑term agreements that can offer stable rental income but also expose the business to sector cycles. Investors should note the company’s exposure to the health‑science ecosystem, which can drive demand and higher rental premiums but may also concentrate tenant risk. Interest rates, development costs and local real‑estate competition influence cash flow and valuations. Alexandria historically targets income through rents and may offer dividend distributions, yet REIT payouts and share prices can fluctuate. This summary is general educational information and not personalised investment advice; suitability depends on an individual’s circumstances and risk tolerance.
Why It’s Moving
Alexandria Real Estate Shares Slip Amid Q3 Earnings Miss and Softening Life Science Market Outlook
- Q3 2025 results showed a 1.1% drop in occupancy and a 0.9% reduction in projected 2025 same property net operating income, signaling softer demand from life science tenants.
- The company signed a record 16-year build-to-suit lease totaling 466,598 RSF with a multinational pharmaceutical tenant, supporting long-term income streams despite near-term headwinds.
- Significant lease expirations aggregating 1.2 million RSF are expected in early 2026 in major markets like Boston and San Francisco with downtime estimated at 6 to 24 months, increasing vacancy risk and pressuring cash flow.
Alexandria Real Estate Shares Slip Amid Q3 Earnings Miss and Softening Life Science Market Outlook
- Q3 2025 results showed a 1.1% drop in occupancy and a 0.9% reduction in projected 2025 same property net operating income, signaling softer demand from life science tenants.
- The company signed a record 16-year build-to-suit lease totaling 466,598 RSF with a multinational pharmaceutical tenant, supporting long-term income streams despite near-term headwinds.
- Significant lease expirations aggregating 1.2 million RSF are expected in early 2026 in major markets like Boston and San Francisco with downtime estimated at 6 to 24 months, increasing vacancy risk and pressuring cash flow.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Alexandria Real Estate Equities' stock with a target price of $84.04, indicating potential growth.
Financial Health
Alexandria Real Estate Equities is experiencing strong revenue and cash flow, showcasing solid financial stability.
Dividend
Alexandria Real Estate Equities offers a high dividend yield of 7.03%, making it appealing for income-focused investors. If you invested $1000 you would be paid $70.30 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
American Tower
American Tower is a real estate investment trust that owns, operates, and develops multi-tenant communications sites.
AGNC INVESTMENT CORP
AGNC Investment is a real estate investment trust that invests in mortgage-backed securities.
AMERICAN HOMES 4 RENT
American Homes 4 Rent is a real estate investment trust and a home rental company that owns and manages single-family homes and other residential properties.
Baskets Featuring ARE
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.
Published: 21 December 2025
Explore BasketReal Estate
Is it sunset or sunrise for real estate stocks? This carefully selected group of property investments, handpicked by our professional analysts, offers exposure to everything from data centers to residential properties and commercial real estate trusts.
Published: 29 May 2025
Explore BasketWhy You’ll Want to Watch This Stock
Demand for Lab Space
The rise in biotech and research activity can increase demand and rents for specialised lab campuses, though occupancy and returns can fluctuate with the sector cycle.
Specialist Tenant Base
Tenants are often research‑intensive firms, which can support premium pricing but also concentrates risk if the life‑sciences sector slows.
Interest‑Rate Sensitivity
Borrowing costs and property valuations respond to interest‑rate changes, so macro moves can affect cash flow and share price.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
